Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRIO DarioHealth	$0.45 +5.1%	$0.66	$0.38 ▼ $1.55	$19.49M	1.24	208,172 shs	399,712 shs
PTHL Pheton	$0.65 -9.1%	$15.10	$0.60 ▼ $32.00	$4.71M	N/A	4.03 million shs	764,164 shs
PYPD PolyPid	$3.49 +2.0%	$3.49	$2.30 ▼ $3.93	$54.37M	1.4	104,612 shs	97,556 shs
STRR Star Equity	$2.46 +22.4%	$2.03	$1.72 ▼ $4.74	$6.48M	0.94	18,068 shs	209,908 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRIO DarioHealth	-14.85%	-19.20%	-40.43%	-35.11%	-55.15%
PTHL Pheton	-8.23%	-28.51%	-96.60%	-85.59%	+71,489,900.00%
PYPD PolyPid	+5.88%	+1.48%	+1.18%	+17.93%	-7.57%
STRR Star Equity	+0.50%	+1.52%	+0.50%	-14.47%	-51.33%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DRIO DarioHealth	1.654 of 5 stars	3.3	1.0	0.0	0.0	0.9	0.8	1.3
PTHL Pheton	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PYPD PolyPid	2.9796 of 5 stars	3.6	5.0	0.0	0.0	2.4	1.7	0.0
STRR Star Equity	3.2391 of 5 stars	3.5	4.0	0.0	0.0	2.1	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRIO DarioHealth	2.67	Moderate Buy	$2.00	344.44% Upside
PTHL Pheton	0.00	N/A	N/A	N/A
PYPD PolyPid	3.17	Buy	$11.80	238.11% Upside
STRR Star Equity	3.00	Buy	$5.00	103.25% Upside

Current Analyst Ratings Breakdown

Latest STRR, PYPD, DRIO, and PTHL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$13.00
6/18/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$12.00 ➝ $9.00
6/17/2025	PYPD PolyPid	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$16.00 ➝ $14.00
6/9/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$11.00 ➝ $13.00
6/5/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$9.00
6/2/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy	$11.00
5/19/2025	DRIO DarioHealth	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$3.00
5/15/2025	STRR Star Equity	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.00 ➝ $5.00

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRIO DarioHealth	$27.04M	0.76	N/A	N/A	$2.11 per share	0.21
PTHL Pheton	$450K	9.50	N/A	N/A	$0.94 per share	0.69
PYPD PolyPid	N/A	N/A	N/A	N/A	$0.75 per share	N/A
STRR Star Equity	$53.36M	0.15	$0.40 per share	6.17	$10.98 per share	0.22

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRIO DarioHealth	-$42.75M	-$0.56	N/A	N/A	N/A	-162.73%	-64.90%	-38.48%	N/A
PTHL Pheton	-$660K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
PYPD PolyPid	-$29.02M	-$4.30	N/A	∞	N/A	N/A	-1,069.37%	-151.85%	8/13/2025 (Estimated)
STRR Star Equity	-$10.44M	-$3.43	N/A	N/A	N/A	-16.43%	-8.24%	-3.48%	8/13/2025 (Estimated)

Latest STRR, PYPD, DRIO, and PTHL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	PYPD PolyPid	-$0.53	-$0.78	-$0.25	-$0.78	N/A	N/A
8/13/2025	Q2 2025	STRR Star Equity	-$0.26	$1.86	+$2.12	$1.07	$16.75 million	N/A
5/14/2025	Q1 2025	DRIO DarioHealth	-$0.07	-$0.14	-$0.07	-$0.14	$7.48 million	$6.75 million
5/14/2025	Q1 2025	PYPD PolyPid	-$0.80	-$0.70	+$0.10	-$0.70	N/A	N/A
5/14/2025	Q1 2025	STRR Star Equity	-$0.25	-$0.52	-$0.27	-$0.37	$16.35 million	$12.92 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRIO DarioHealth	N/A	N/A	N/A	N/A	N/A
PTHL Pheton	N/A	N/A	N/A	N/A	N/A
PYPD PolyPid	N/A	N/A	N/A	N/A	N/A
STRR Star Equity	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRIO DarioHealth	0.26	2.01	1.77
PTHL Pheton	N/A	12.39	12.17
PYPD PolyPid	4.43	0.71	0.71
STRR Star Equity	0.22	1.42	0.88

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DRIO DarioHealth	33.39%
PTHL Pheton	N/A
PYPD PolyPid	26.47%
STRR Star Equity	3.84%

Insider Ownership

Company	Insider Ownership
DRIO DarioHealth	11.20%
PTHL Pheton	N/A
PYPD PolyPid	24.70%
STRR Star Equity	33.51%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DRIO DarioHealth	200	45.51 million	40.41 million	Optionable
PTHL Pheton	11	6.58 million	N/A	N/A
PYPD PolyPid	80	15.90 million	11.97 million	No Data
STRR Star Equity	460	3.23 million	2.15 million	Not Optionable

STRR, PYPD, DRIO, and PTHL Headlines

Recent News About These Companies

Star Equity reports Q2 EPS $1.86 vs (29c) last year

August 13 at 2:50 PM | msn.com

Star Equity Holdings, Inc. (STRR) Q2 2025 Earnings Call Transcript

August 13 at 1:04 PM | seekingalpha.com

Star Equity (STRR) Tops Q2 Earnings and Revenue Estimates

August 13 at 10:46 AM | zacks.com

Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

August 13 at 8:30 AM | globenewswire.com

Earnings Outlook For Star Equity Hldgs

August 12 at 6:45 PM | benzinga.com

Star Equity Holdings Inc (STRR) Q2 2025 Earnings Report Preview: What To Expect

August 12 at 6:45 PM | finance.yahoo.com

Star Equity (STRR) Projected to Post Earnings on Wednesday

August 12 at 2:33 AM | americanbankingnews.com

Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

August 8, 2025 | globenewswire.com

STAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity Holdings, Inc. - STRR

August 5, 2025 | businesswire.com

Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13

August 4, 2025 | globenewswire.com

STAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity ...

May 24, 2025 | morningstar.comM

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

May 24, 2025 | financialpost.comF

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

May 24, 2025 | financialpost.comF

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

May 24, 2025 | globenewswire.com

STAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity Holdings, Inc. - STRR

May 22, 2025 | businesswire.com

Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 for Preferred Stockholders

May 22, 2025 | nasdaq.com

Hudson Global, Inc.: Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

May 22, 2025 | finanznachrichten.de

STRR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Star Equity Holdings, Inc. Is Fair to Shareholders

May 21, 2025 | businesswire.com

Star Equity Holdings, Inc. and Hudson Global, Inc. Announce Definitive Merger Agreement to Form NewCo

May 21, 2025 | quiverquant.comQ

Star Equity Holdings, Inc. and Hudson Global, Inc. Announce Merger Agreement to Form NewCo

May 21, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR, PYPD, DRIO, and PTHL Company Descriptions

DarioHealth NASDAQ:DRIO

$0.45 +0.02 (+5.07%)

Closing price 04:00 PM Eastern

Extended Trading

$0.45 0.00 (-0.44%)

As of 07:03 PM Eastern

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Pheton NASDAQ:PTHL

$0.65 -0.06 (-9.08%)

Closing price 04:00 PM Eastern

Extended Trading

$0.68 +0.03 (+5.23%)

As of 07:55 PM Eastern

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

PolyPid NASDAQ:PYPD

$3.49 +0.07 (+2.05%)

Closing price 04:00 PM Eastern

Extended Trading

$3.50 +0.01 (+0.43%)

As of 05:15 PM Eastern

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Star Equity NASDAQ:STRR

$2.46 +0.45 (+22.39%)

Closing price 03:59 PM Eastern

Extended Trading

$2.43 -0.03 (-1.22%)

As of 07:52 PM Eastern

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time